Cycled phototherapy in treatment of neontal jaundice

Comparison of cycled phototherapy with continuous phototherapy in treatment of jaundice in premature VLBW neonates

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211218053444N1

Enrollment

150

Registered

2022-02-22

Start date

2022-03-05

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Jaundice. ???? ???????

Interventions

Intervention group: The effect of periodic phototherapy on VLBW neonates Control group: Effect of permanent phototherapy on VLBW neonates . Neonates will be classified into two gro

Eligibility

Sex/Gender

All

Age

1 Days to 1 Days

Inclusion criteria

Inclusion criteria: Weight 1000 to 1500 grams Failure to receive previous phototherapy Need to receive phototherapy Age less than 24 hours

Exclusion criteria

Exclusion criteria: Known hemolytic disease Asphyxia Non-bacterial infection overt Existence of major anomalies Unstable conditions (arterial blood pH less than 6.8 for more than 2 hours, stable bradycardia associated with hypoxia for more than 2 hours) Unwanted consent of the baby's parents or legal guardian to enter the study

Design outcomes

Primary

Measure	Time frame
Neonatal jaundice rate. Timepoint: Fourteen days. Method of measurement: Serum bilirubin levels.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Jamali

Kerman University of Medical Sciences

z.jamali@kmu.ac.ir031328000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026